Ann: Kazia Half Year Accounts and Chairman's letter, page-91

see this what we need ...

thanks PB that shows we are above but close to 50% of SP value at the time of purchase of GDC now it's in multiple trials human trials and nearly a pivotal study etc - that's an interesting chart one I would not have done though I look at charts and it's really interesting at that setting - it clearly shows the more recent growing bullish sentiment in SP and it's not lost on me we continue to hear of clinicians excitement etc etc... its all growing

I think any good news will be a force multiplier here now each good news event confirms the other etc.

outstanding 'early glimpses' then become 'concrete evidence... if we get one or two more data releases showing a material benefit then Edison's current valuations will be met... and they will adjust up too.